NIVF - NewGenIvf Group Limited 0 WATCHERS

NIVF 🟡 https://finance.yahoo.com/news/nivf-ytd-financial-results-generally-130700548.html

If NIVF not performing well would be smart to sell it and buy BYND

IVF ，Wbuy ,NIVF , TRNR SGN , NAKA. AND VEEE

Nice. Looks good: [BYND](http://aimytrade.io/ticker/BYND) [NIVF](http://aimytrade.io/ticker/NIVF)

I hold BYND 90% and NIVF 10% in my penny stock portfolio BYND is a big community NIVF is a serial shell, no one know when it will be real

Small-Cap Flow: NIVF Volume Explodes on $2M Buyback, Bids Firm at $0.33 NIVF's trading volume surged post the November 19 $2M share repurchase news, holding the line at $0.33 with clear buying support below $0.34—classic small-cap accumulation. The 24-month program (>50% mcap) pairs with the reverse split's compliance and SAXA's …

Penny NIVF at $0.33: Repurchase Volume Spike Signals 10x Setup Sub-$0.40 NIVF saw volume multiply after yesterday's $2M buyback announcement (Nov 19), stabilizing at $0.33 on heavy bids around $0.32-$0.34. This 24-month, cash-funded effort (>50% mcap) reinforces the undervaluation thesis ahead of SAXA's $5B mining unlock. I see this elevated …

Value Check: NIVF's $2M Buyback at $0.34 Enhances Margin of Safety NIVF's price fell 3.27% to $0.34 today, trading well below cash per share. The $2M repurchase program (authorized Nov 10, 24-month window) explicitly addresses undervaluation, aligning with Graham principles amid the SAXA merger's asset infusion. This could accretively lift …

NIVF A key overhang on NIVF’s equity stems from its early-stage reliance on convertible debt to fund operations amid cash burn in its core fertility business. In Q1 2025, the company issued a $2 million senior convertible note carrying a 14.75% annual interest rate, part of a broader $5.2 million …

Steady Look at NIVF: Recent Developments Amid Price Dip to $0.35 In the small-cap space, NIVF stands out with its November pivot: a proposed reverse merger with SAXA for $5B in high-value mining assets (gold, silver, rare earths). The stock's hovered around $0.35 lately, post a November 10 reverse split …

NIVF, can anyone share views regarding the reasons why it keeps rolling down while the net asset value is 10 times higher

At current levels near $0.35, NIVF's tenbagger narrative hinges on the November 3 reverse merger with SAXA, valued at $380M but tapping $5B+ in gold/silver/rare earth assets. The $2M repurchase (November 10) and reverse split signal commitment amid the dip. Post-merger, asset backing could re-rate the stock significantly. Low float …

Bought some $NIVF for some reasons it maybe reverse spilt in december, price down mainly due to skilful investor’s structural financing pressured on the share price but the conversion amount getting smaller, and the marcap now only 1/10 of its net asset value. Risky of pump and dump but risk …